EUVIMEDEUVIMED entdecken
Crossref

Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice

Kegong Tang, Xiaona Wang, Yu Zhao, Xiaobei Li, Zhenyu Jiang, Song Mei, Mingrui Chen, Yiming Ma, Xinyi Du, Xiangyu Qiao, Na Sun, Jiaqi Liu und 1 weitere

Science China Life Sciences · 2023

DOI: 10.1007/s11427-022-2275-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science China Life Sciences, 2023. Verfasst von Kegong Tang und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemist…. Hauptthemen laut MEDLINE: Angiotensin II, Hypertension. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension has become a growing public health concern worldwide. In fact, hypertension is commonly associated with increased morbidity and mortality. Currently, oligonucleotide drugs have proven to be promising therapeutic agents for various diseases. In the present study, we aimed to demonstrate that a herbal small RNA (sRNA), XKC-sRNA-h3 (B55710460, F221. I000082.B11), exhibits potent antihypertensive effects by targeting angiotensin-converting enzyme (ACE) in mice. When compared with captopril, oral administration of the sphingosine (d18:1)-XKC-sRNA-h3 bencaosome more effectively prevented angiotensin II-induced hypertensive cardiac damage and alleviated kidney injury in mice. Such findings indicated that XKC-sRNA-h3 may be a novel orally available ACE inhibitor type oligonucleotide drug for hypertension.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIHypertensionMiceAnimalsAngiotensin-Converting Enzyme InhibitorsCaptoprilAdministration, OralBlood Pressure

Stichwörter der Autor:innen

hypertensionoligonucleotide drugoral administration

Substanzen

Angiotensin IIAngiotensin-Converting Enzyme InhibitorsCaptopril

Autor:innen und Institutionen

  • State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry, Peking Union Medical College, Beijing, 100005, China.
  • State Key Laboratory of Medical Molecular Biology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Department of Biochemistry, Peking Union Medical College, Beijing, 100005, China. jiang@pumc.e…

Zitieren

APA

Tang, K., Wang, X., Zhao, Y., Li, X., Jiang, Z., Mei, S., Chen, M., Ma, Y., Du, X., Qiao, X., Sun, N., Liu, J., & Jiang, C. (2023). Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice. Science China Life Sciences. https://doi.org/10.1007/s11427-022-2275-3

Vancouver

Tang K, Wang X, Zhao Y, Li X, Jiang Z, Mei S, et al. Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice. Science China Life Sciences. 2023. doi:10.1007/s11427-022-2275-3

BibTeX
@article{Tang2023,
  author = {Tang, Kegong and Wang, Xiaona and Zhao, Yu and Li, Xiaobei and Jiang, Zhenyu and Mei, Song and Chen, Mingrui and Ma, Yiming and Du, Xinyi and Qiao, Xiangyu and Sun, Na and Liu, Jiaqi and Jiang, Chengyu},
  title = {Oral administration of the herbal oligonucleotide XKC-sRNA-h3 prevents angiotensin II-induced hypertension in mice},
  journal = {Science China Life Sciences},
  year = {2023},
  doi = {10.1007/s11427-022-2275-3}
}
Kostenlos starten →